Stay updated on FT596 in Monotherapy and Combo with Anti-CD20 mAbs Clinical Trial

Sign up to get notified when there's something new on the FT596 in Monotherapy and Combo with Anti-CD20 mAbs Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the FT596 in Monotherapy and Combo with Anti-CD20 mAbs Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Difference
    0.4%
    Check dated 2025-05-08T04:55:59.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.6%
    Check dated 2025-05-01T01:17:15.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Difference
    0.7%
    Check dated 2025-04-23T18:07:34.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the removal of detailed descriptions of a Phase I study involving FT596, Rituximab, and Obinutuzumab for B-cell lymphoma and chronic lymphocytic leukemia. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.
    Difference
    17%
    Check dated 2025-04-16T14:10:53.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.7%
    Check dated 2025-04-09T08:49:04.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to reflect a change in terminology from 'Lymphosarcoma' to 'B-cell Lymphoma' and has been revised from version 2.14.2 to 2.14.3.
    Difference
    0.7%
    Check dated 2025-04-01T23:05:22.000Z thumbnail image

Stay in the know with updates to FT596 in Monotherapy and Combo with Anti-CD20 mAbs Clinical Trial

Enter your email address, and we'll notify you when there's something new on the FT596 in Monotherapy and Combo with Anti-CD20 mAbs Clinical Trial page.